Incidence, Risk Factors, and Outcome of Immune-Mediated Neuropathies (IMNs) following Haploidentical Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Incidence, Risk Factors, and Outcome of Immune-Mediated Neuropathies (IMNs) following Haploidentical Hematopoietic Stem Cell Transplantation

Published:2019-08 Issue:8 Volume:25 Page:1629-1636
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ren Xi-ying,Liu Xiao,Huang Qiu-sha,Wang Qian-ming,He Yun,Zhu Xiao-lu,Han Wei,Chen Huan,Chen Yu-hong,Wang Feng-rong,Wang Jing-zhi,Zhang Yuan-yuan,Mo Xiao-dong,Chen Yao,Wang Yu,Fu Hai-xia,Chang Ying-jun,Xu Lan-ping,Liu Kai-Yan,Huang Xiao-Jun,Zhang Xiao-hui

Funder

National Natural Science Foundation of China

Beijing Natural Science Foundation

Beijing Municipal Science and Technology Commission

Basic Research Program of China

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference49 articles.

1. Haploidentical stem cell transplantation for the treatment of leukemia: current status;Chang;Exp Rev Hematol,2014

2. Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study;Wang;Blood,2015